|
|||||
|
|
Second-line erlotinib in an EGFR mutation-negative patient with non-small-cell lung cancer |
|
| Authors: | Hirsh Vera |
| Affiliation: | Medical Oncology Department, MUHC Royal Victoria Hospital, 687 Pine Avenue West, Suite A3.04, Montreal, Quebec H3A 1A1, vera.hirsh@muhc.mcgill.ca. |
| Abstract: | |
| Keywords: | Non-small-cell lung cancer erlotinib gefitinib egfr mutation |
| 本文献已被 PubMed 等数据库收录！ | |